A detailed history of Lecap Asset Management LTD transactions in Eli Lilly & CO stock. As of the latest transaction made, Lecap Asset Management LTD holds 760 shares of LLY stock, worth $686,059. This represents 0.15% of its overall portfolio holdings.

Number of Shares
760
Holding current value
$686,059
% of portfolio
0.15%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 23, 2024

BUY
$724.87 - $909.04 $550,901 - $690,870
760 New
760 $688 Million
Q4 2023

Jan 29, 2024

BUY
$525.19 - $619.13 $361,855 - $426,580
689 New
689 $402 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $858B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Lecap Asset Management LTD Portfolio

Follow Lecap Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lecap Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Lecap Asset Management LTD with notifications on news.